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Staphylococcus pseudintermedius affecting dogs is analogous to S. aureus on humans, 
acting as both normal flora and opportunistic pathogen.  Methicillin resistance in S. 
pseudintermedius is recent, with the first documented occurrence of an isolate bearing 
the methicillin resistance gene, mecA, in 1999.  This gene encodes penicillin binding 
protein 2a, which renders all β-lactam drugs ineffective and functions as a “gateway” 
antibiotic resistance determinant.  In the presence of ineffective antibiotics, 
opportunities for mutational events and acquisition of mobile genetic elements increase 
as microbial densities increase, often leading to multi-drug resistance.  MRSP infections 
have become increasingly common.  For example, approximately 30% of the S. 
pseudintermedius isolates tested by the UTCVM Diagnostic Bacteriology service are 
resistant to methicillin.  An increasing number of MRSP isolates are also resistant to 
most clinically useful antibiotics available to veterinarians except for chloramphenicol, 
and resistance to this antibiotic is common among European MRSP isolates.  
Chloramphenicol resistance has begun to appear in the US and if this trend continues 
there may soon be few viable antibiotic treatment options.  
Compared with the arrival of MRSA in the 1960s, the opportunity currently exists to 
apply advanced molecular methods early in this recognized emergence of MRSP.  To 
that end I have pursued projects utilizing multilocus sequence typing, pulsed-field 
electrophoresis, and SCCmec characterization of both susceptible and resistant S. 
pseudintermedius.  The initial result was the detection of a clonal population of MRSP in 
the southeastern United States.  Further characterization of this and other clonal 
lineages using genomic sequencing and real-time RT-PCR expression analysis of 
antibiotic resistance and quorum sensing genes revealed a marked difference in the 
regulation of antibiotic resistance between regional clones.  These discoveries have 
interesting epidemiological implications and provide a foundation for the development 
of novel therapeutics to circumvent the expanding antibiotic resistance repertoire of 
MRSP.  Potential targets identified by this work include membrane-bound beta-
lactamase receptors responsible for the regulation of mecA, non-cognate auto-inducing 
peptides, and synthetic antisense oligonucleotides. 
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Chapter 1: Literature Review 
Overview 
 
A synthetic form of penicillin, methicillin, was introduced in 1959 to treat 
Staphylococcus aureus resistant to -lactam antibiotics. Within a year the first 
methicillin-resistant S. aureus (MRSA) isolates began to appear in hospital settings.2 
Methicillin-resistance is a “gateway” antibiotic resistance determinant.  It causes 
penicillins and cephalosporins to become ineffective, establishing a MRSA foothold in 
the hospital environment and on the patient repeatedly exposed to first-line antibiotics.  
From that foothold, the organism has the opportunity to acquire mutations and further 
transmissible elements that increase its multi-drug resistance repertoire.  Methicillin-
resistance often leads to multi-drug resistance.  In the fifty years since methicillin 
resistance appeared in S. aureus, MRSA infection has become the sixth-leading cause of 
death in hospitalized human patients in the United States, with costs estimated to be 
between 4 and 6 billion dollars annually.2,3  
Staphylococcus pseudintermedius on dogs is analogous to S. aureus on humans, acting 
as both normal flora and opportunistic pathogen.  It is the primary cause of pyoderma, 
the most common dermatologic disease seen in dogs, and is also frequently associated 
with urinary tract infections and wound and surgical site infections.4 The first 
documented isolate of S. pseudintermedius bearing the methicillin resistance gene mecA 
occurred in 1999.5 Since that discovery, methicillin-resistant S. pseudintermedius (MRSP) 
infections have become increasingly common.  Approximately 30% of the staphylococcal 
isolates tested by the University of Tennessee College of Veterinary Medicine (UTCVM) 
Bacteriology Service are resistant to methicillin.6-8 These bacteria also carry resistance to 
almost all clinically useful antibiotics except for chloramphenicol and the ones reserved 
for use in humans. Resistance to chloramphenicol is now beginning to appear, leaving 
no viable therapeutic options.   
Methicillin resistance in S. aureus has been studied in far greater detail than in S. 
pseudintermedius; despite significant dissimilarities in genomic sequence the two 
species share a natural history, as well as many of the same regulatory, antimicrobial, 
and virulence determinants.  Biochemical and molecular techniques used in the study of 
S. aureus can and have often been adapted to S. pseudintermedius.  Therefore, much of 
the literature regarding S. aureus is applicable to the study of staphylococci as a whole.  
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The following is a review of the nomenclature, phenotype, genetic characterization of 
methicillin resistance, and typing methodologies for S. pseudintermedius. 
 
The Taxonomic History of Staphylococcus pseudintermedius 
 
The defining characteristics of bacterial species have changed with advances in 
technology.   With the proliferation of molecular characterization techniques and the 
increased accessibility of genomic sequencing platforms, the inevitable taxonomic trend 
is toward diversification within the bacterial genus.  The 19th century Scottish physician 
Alex Ogston was an early proponent of the role of microscopic spherical organisms 
(“micrococci”) in acute inflammation and suppuration associated with abscess 
formation in skin.  He was also one of the first to make the leap connecting microbial 
abscessation with the circulatory phenomena of septicemia and pyemia.9,10 These 
foundational observations hold true in the clinical presentation of staphylococcal 
infection today.  In 1882 he coined the term Staphylococcus – from the Greek staphulê 
for bunch of grapes – to differentiate cluster-forming micrococcus from the chain-
forming variety then known as Billroth’s streptococci.11 Rosenbach further subdivided 
staphylococci in 1884 on the basis of color on culture media – S. aureus and S. albus for 
gold and white colony formation respectively.12 For the next ninety years the 
Staphylococcus genus was widely held to have only three distinct species.  During this 
period gram-positive, coagulase-positive, hemolytic isolates with variable colony 
coloration and associated with disease in both humans and animals were presumed to 
be S. aureus; whereas non-pathogenic, coagulase-negative staphylococci (CoNS) with 
white colony coloration were classified as either S. epidermidis (formerly albus) or S. 
saprophyticus and considered to be environmental contaminates.12-14 
Review of veterinary microbiology textbooks from the 1930s through the late 1960s 
supports the bias towards S. aureus as the catchall designation for pathogenic gram-
positive and coagulase-positive clustering cocci.  Variations in S. aureus microscopic size, 
hemolytic ability, and colony coloration were often noted, prompting calls for greater 
research into the validity of species designation.15-18 From Merchants 1968 edition of 
Veterinary Bacteriology and Virology the follow observation is made concerning the use 
of pigmentation as the sole criteria for staphylococcal differentiation, 
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(S. Epidermidis) has been considered by many to be only a non-
pigmented variant of the aureus strains.  It is readily apparent to those 
who study the staphylococci that numerous non-pigmented strains can 
be isolated.  In fact, unless isolation is made upon special media, such as 
no. 110, colonies of staphylococci are sometimes white.  
The designation of strains of any organism, one variety or 
another, on the basis of colony color without specification of growth is 
most confusing, not only to the student but to anyone interested in 
taxonomy.  .  .  . 
It is quite apparent that additional research must be done on the 
genus Micrococcus (Staphylococcus) in order to clarify many of the 
interrelationships of the members of this genus.15 
 
This admonition in a standard veterinary text of the time suggests that as late as the 
early 1970s some veterinary practitioners were dismissing the as yet uncharacterized S. 
intermedius as nonpathogenic based primarily on colony color. 
In the latter half of the 20th century, spurred by the emergence of new hospital-acquired 
and antibiotic-resistant infections, both human and veterinary medical microbiologists 
began to actively pursue a better understanding of which organisms were associated 
with specific types of infections and hosts.  The improvements made in both phenotypic 
biochemical testing and genotypic molecular tests resulted in the diversification of both 
coagulase-positive and negative staphylococcal species.13,16,19 At the time of writing 
there are 41 species and 24 subspecies cited in the genus Staphylococcus.20 
The earliest call for a more precise designation for coagulase-positive staphylococci of 
canines came in 1947, with Smith’s observation that not all suspected pathogenic strains 
from canines reacted uniformly in tube, slide and plate agglutination tests; and that 
canine isolates were discernable from those of other animals by cultural characters and 
toxin formation.21 Based upon confirmation of Smith’s work, a 1967 report proposed the 
name S. aureus var. canis and described biochemical and staining differences between 
isolates from different host species.  The study showed that canine isolates consistently 
failed to coagulate human serum, pigmentation lacked the characteristic golden hue, 
and crystal-violet staining, fibrinolysin production, hemolysis type and phage type did 
not consistently match between human and canine isolates.22 A series of cross-reactivity 
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experiments by I. Live of Pennsylvania and V. Hajek of Czechoslovakia further explored 
the coagulase and fibrinolysis disconnect observed when isolates of one background 
were exposed to blood components of the other.  Not only did these findings have 
bearing on speciation, they were an early suggestion that staphylococci of canine origin 
may be more host-adapted than the human equivalent, S. aureus.23-25 In 1976 Hajek 
reported the results of a battery of additional biochemical tests that when applied to 
coagulase-positive staphylococci of animal origin (pigeon, canine, mink, and horse) 
justified a new species name, S. intermedius.  The name was chosen to indicate the 
group’s intermediate phenotypic position between the coagulase-positive S. aureus and 
the white colony formation of S. epidermidis.  Despite evidence of biochemical 
differences between isolates from the different animals within the study, a pigeon 
isolate became the type strain for S. intermedius.16 With the biochemical profile 
established for species identification, reports from the 1980s through 2007 consistently 
demonstrated S. intermedius to be the primary staphylococcal normal flora and 
opportunistic pathogen of canines.26-30  
The improvement of molecular typing methods in the 1980s and 90s provided additional 
tools for the description of bacterial species.  In 2005 Devriese et al. described a novel 
staphylococci based on 16S rRNA gene sequence analysis and confirmed by DNA-DNA 
hybridization its dissimilarity with S. intermedius, S. delphini and S. schleiferi subsp. 
schleiferi type strains.  The name S. pseudintermedius was chosen because the new 
species was difficult to distinguish from S. intermedius with standard phenotypic tests.31 
Because 16S rRNA gene sequence differed so little (>99% homology) among the S. 
intermedius group (SIG includes S. intermedius, S. delphini, and S. pseudintermedius), 
subsequent research expanded phylogenetic analysis with sodA and hsp60 gene 
sequences.  Whereas the Devriese group based its findings on four isolates, one each 
from a cat, dog, horse and parrot, Sasaki et al. analyzed 117 isolates with the S. 
intermedius phenotype and primarily of canine and pigeon origin.  They found that all 
canine isolates (n=78) were S. pseudintermedius and that all pigeon isolates were not.   
The ATCC S. intermedius type strain (acquired from the Hajek 1976 study) clustered only 
with isolates from wild pigeons.  This finding was the first strong indication that the 
newly identified S. pseudintermedius was inherently linked to the canine host.32   
Further evidence for replacing S. intermedius with S. pseudintermedius as the 
opportunistic staphylococcal pathogen of canines was given by Bannoehr et al. in 2007.  
The group created a four-component multilocus sequence typing (MLST) analysis using 
chaperonin 60 (cpn60), phosphate acetyltransferase (pta), elongation factor tu (tuf), and 
accessory gene regulator locus D (agrD) in addition to 16S rRNA.  They tested 105 SIG 
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isolates from various hosts and from ten countries in North America, Europe, and Asia.  
Their findings mirrored those of Sasaki et al. in that all S. pseudintermedius isolates 
identified with this method were found on dogs.33 Based upon these studies the current 
consensus for SIG nomenclature is to categorize as S. pseudintermedius all canine 
isolates that have the S. intermedius phenotype.  Therefore, the following terms and 
abbreviations are a convenient method of classification31,34,35: 
1. S. (pseud)intermedius when isolates previously identified as S. 
intermedius are likely S. pseudintermedius (obtained from a canine host) 
2. MRS(P)I for methicillin-resistant S. (pseud)intermedius (formerly 
classified as MRSI but obtained from a canine host) 
3. MRSP for isolates identified as S. pseudintermedius via methods that 
have appeared in more recent literature. 34,35  
 
The History of Methicillin Resistance in S. pseudintermedius 
 
In studies from the 1980s, all veterinary staphylococcal isolates tested were susceptible 
to methicillin.36,37 The first report of methicillin resistance in S. (pseud)intermedius 
confirmed by PCR detection of mecA occurred in 1999 from a single isolate in a survey of 
25 staphylococcal isolates of canine origin.  In that study, both coagulase-positive and 
negative isolates were screened; but interestingly, all other coagulase-positive 
methicillin-resistant isolates were found to be S. aureus.  This occurred at the University 
of Illinois, and the sample set had been collected from 1995 forward. Several possible 
explanations exist for the detection and/or emergence of a single and novel MRS(P)I at 
this time.  The first is that a confluence of events provided the necessary elements for 
acquisition of a SCCmec by S. (pseud)intermedius: 
1. A high prevalence of MRSA among staphylococci responsible for hospital-
acquired infections (>50%) meant that the raw numbers of mobile 
genetic elements (MGE) bearing mecA were high relative to the past.35 
2. The emergence of CA-MRSA infections not linked to HA-MRSA indicated 
that MGEs had made the intra-species transition from one set of lineages 
to another – mecA and SCCmec was on the move.38 
3. The use of -lactam antibiotics and cephalosporins in human and animal 
medicine, as well as in food animal production may have reached a 
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critical mass, facilitating not only the acquisition, but also the 
maintenance of the SCCmec in S. (pseud)intermedius.39,40  
 
While all these elements were certainly in place, another reason for the late arrival of 
methicillin resistance in the S. intermedius literature relative to its arrival in S. aureus 
may simply be due to the sensitivity of speciation and screening methodologies.  The 
Spanish group Piriz et al. reported an apparently novel and large proportion of 
methicillin-resistant isolates in a sampling of S. (pseud)intermedius collected between 
1988 and 1992; however, they did not verify the presence of mecA and found widely 
varying levels of methicillin resistance when adjusting the culture alkalinity for canine 
physiology.41 It is important to consider that the speciation of coagulase-positive 
staphylococci was nebulous prior to the mid-1970s, and that appropriate standards for 
speciation and methicillin resistance determination in staphylococci of animal origin 
continue to evolve through the present.6 When molecularly screening UTCVM isolates 
and samples submitted by collaborators for species identity, the Bacteriology and 
Immunology Services often find S. aureus, S. pseudintermedius, S. intermedius, S. 
delphini and S. schleiferi coagulans phenotypically misidentified. Perhaps S. intermedius 
lineages bearing the mecA gene existed for some time prior to the mid-1990s and were 
misclassified as MRSA or expressed mecA at less detectable levels when tested using S. 
aureus standards. The exact point in time where S. pseudintermedius acquired mecA is 
not vital to present treatment and control of MRSP expansion.  However, historical 
review of the literature provides a foundation and informs upon how mecA might move 
from one organism to another, and from what ecological repositories resistance genes 
like mecA arise.  Understanding the frequency and mode of SCCmec horizontal transfer, 
through in-depth molecular population analysis, enables the identification of clinically 
relevant MRSP lineages and sheds light on the frequency at which novel lineages 
appear.   
 
The Utility of Genotypic Methods for Staphylococcal Population Analysis 
 
Horizontal gene transfer (HGT) incidence is an important part of determining zoonotic 
potential of MRSP.  As yet there is no evidence that SCCmec from canine normal flora S. 
pseudintermedius can transfer to human S. aureus or vice versa.  Interspecies SCCmec 
transfer is likely a rare event in that no research group has yet demonstrated such 
movement experimentally.  However, there is compelling evidence from a 2001 Dutch 
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case report concerning a premature infant treated with potentiated amoxicillin while in 
a neonatal intensive care unit.  Prior to antibiotic therapy a mecA negative MSSA was 
cultured.  Following antibiotic treatment failure ten days later, a MRSA was isolated with 
the same genetic background as the previously identified MSSA, as well as CoNS with an 
identical SCCmec to that of the MRSA.42 The neonatal intensive care unit had strict 
infection control procedures in place, and cultured at all stages of treatment.  One 
plausible explanation for the appearance of this novel MRSA was that the SCCmec 
transferred from CoNS to MSSA and the antibiotic given insured selection of the newly 
formed MRSA. 
Investigations of MRSA genotype in large populations are essentially attempting to 
replicate the findings on the Dutch baby at the regional or national level.  Understanding 
the movement of SCCmec requires that researchers adopt a consistent typing scheme.  
Prior to the molecular age, tools for bacterial characterization included phenotypic 
speciation, antibiogram profile, and phage typing.   Over the past two decades 
methodologies have been developed that allow investigators to apply numerical values 
to genetic relatedness within a species.  Molecular techniques have also been 
developed that describe the relatedness of resistance cassettes SCCmec. The following is 
a summary of genotypic methods applied to staphylococci.  These are some of the 
approaches that can demonstrate associations between bacterial lineages and 
resistance determinanants.  
 
Staphylococcal Cassette Chromosome (SCCmec) Typing 
 
Known SCCmecs are relatively large for MGEs, ranging in size from 30 to 55KB.  The 
essential components used to characterize SCCmec are the genetic sequences of the 
mec and ccr gene complexes.  The mec operon is composed of mecA, a promoter region, 
and some or all of the regulatory genes mecI (promoter inhibitor) and mecR1 
(membrane-bound -lactam sensor). The ccr gene complex encodes the recombinases 
responsible for cassette excision from and integration into the bacterial chromosome.43 
To date sequence analysis has identified five classes of mec complex (A, B, C1, C2, and E 
based upon the completeness of the operon) and five ccr allotypes (ccrAB1 to ccrAB4 
and ccrC) in major MRSA lineages.  SCCmec type is designated by a roman numeral (I-
VIII) and represents a combination of mec class and ccr allotype.44 Because the cassettes 
are so large, extensive sequencing would be required to fully characterize each one.  To 
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bypass this laborious process, numerous multiplex PCR schemes have been described, 
amplifying sequences specific to each mec and ccr region by SCCmec type.  The inherent 
drawback to these PCR-based techniques is that any novel cassette type is either 
misclassified because the small regions amplified by the assay are by chance similar to 
the described cassette type, or it is untypeable and must be fully sequenced and a new 
multiplex approach developed.  Low frequency untypeable cassettes are often reported 
in large surveys of methicillin-resistant staphylococci.  The greatest utility of the 
cassette-typing multiplex PCR approaches are their ability to identify the most common 
SCCmecs in the predominant MRSA clonal lineages.  As will be discussed in proceeding 
studies, the multiplex PCR developed by Zhang et al. for MRSA is sufficient to classify 
MRSP SCCmec types II-III and VT in predominant clonal lineages ST 71 and ST 68 
respectively.45,46 
The MRSA SCCmec typing nomenclature has been used for characterization of SCCmec 
in other staphylococci.  Cassettes are likely similar across species; SCCmec is a MGE 
believed to be restricted to staphylococci, and similar cassette types would presumably 
be interchangeable between S. aureus, S. pseudintermedius and the CoNS.  Three 
cassettes associated with S. pseudintermedius have been fully characterized.47,45 
Descloux et al. described two cassettes.  SCCmec type II-III was identified in 14 of 15 
MRSP isolates screened, and SCCmec type VII in a single isolate.  SCCmec II-III was found 
to be a hybrid of S. aureus SCCmec III and S. epidermidis SCCmec II, and associated with 
the most common European MRSP sequence type, ST 71.  MRSP SCCmec VII had novel 
ccr regions, some similarity to MRSA SCCmec III, but an incomplete mec operon.  The 
“take-home” message from the Descloux study is that even though the emergence of 
methicillin-resistance in S. pseudintermedius is recent, the movement of cassettes 
between staphylococci is not a simple transaction whereby the recipient receives an 
exact copy from the donor.  No MRSP has yet been shown to carry an exact copy of a 
MRSA SCCmec.  Something about the as yet unidentified mechanism of cassette transfer 
between staphylococci causes some level of recombination or deletion.  An alternative 
explanation could be that direct MRSA to MRSP cassette transfer does not occur, and 
the genetic shuffling of the cassettes happens in a reservoir species, such as a 
commensal nonpathogenic CoNS.  
The third known MRSP SCCmec type (type VT associated with ST 68) was sequenced and 
described by Eberlein and Kania at UTCVM, and will be part of the study described in 




Methods for Sub-Typing S. aureus and S. pseudintermedius 
 
Because SCCmec is mobile, cassette typing alone is insufficient to characterize MRS and 
incapable of describing susceptible lineages.  Therefore, typing methods have been 
developed that focus on areas of genetic variability shared by all isolates.  Depending 
upon the desired resolution of the bacterial population picture, the following strategies 
have been used to type staphylococcal isolates (listed in order from highest to lowest 
specificity): pulsed-field gel electrophoresis (PFGE), multiple-locus variable-number 
tandem-repeat analysis (MLVA), spa typing, and multilocus sequence typing (MLST).48 
 
Pulsed-Field Gel Electrophoresis 
 
PFGE is among the most discriminative of the typing methods, and is the foundation of 
the Center for Disease Control (CDC) Pulsenet initiative for standardized molecular 
subtyping of foodborne disease-causing bacteria such Escherichia coli O157:H7, 
Salmonella, Shigella, Listeria, or Campylobacter.49 No PCR amplification is required.  
Chromosomal DNA is isolated and then digested with a restriction enzyme; for 
staphylococci the enzyme most often used is SmaI.  Depending upon the number and 
location of restriction sites within the genome, a characteristic number of fragments are 
produced.  Those fragments range from >100KB to <5KB and are separated on agarose 
gel by alternating voltage across an electric field.  The gel banding patterns are then 
assessed by statistical software and assigned a percent similarity relative to one 
another.50 Because the frequency of point mutations that can add or delete restriction 
sites is high, pulsed-field patterns change relatively quickly through successive bacterial 
generations.   PFGE is most useful when comparing isolates within a close population, 
such as within a single hospital or between a series of patients.  The primary 
impediment to wide scale use of PFGE is difficulty with reproducibility between 
laboratories.  It is a labor-intensive process, and the banding patterns vary greatly 
depending upon the agarose gel, power supply settings, and analysis software used.   
Attempts to standardize PFGE for S. aureus have occurred at the federal level in the 
United States and Europe, with its addition to Pulsenet by the CDC and the European 
Union Harmony protocol respectively.51,52 No such attempt has been made to 
standardize S. pseudintermedius PFGE.  Researchers of animal staphylococci typically 
use PFGE to add validity to the results of less discriminating typing methodologies (MLST 
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or spa typing)45,46,53, or to track closely related isolates in carriage studies between 
animals or on different locations of a single animal.54,55 
 
Multilocus Variable Number Tandem Repeat Analysis (MLVA) and spa Typing 
 
MLVA and spa typing fall between PFGE and MLST in their discriminatory ability, and are 
therefore used where appropriate for study focus, sample size and cost-effectiveness.  
Like MLST, both are PCR-based techniques that have the advantage of being highly 
reproducible between facilities.  MLVA is a multiplex PCR analyzing the variation in 
number of repeats in seven individual S. aureus genes (sspA, spa, sdrC, sdrD, sdrE, clfA, 
and clfB).56 In several MRSA studies MLVA was found to be comparable in discriminatory 
power with PFGE.48,57 Due to reduced need for expensive single-purpose equipment and 
specialized training, MLVA may eventually replace PFGE as the method of choice for CDC 
Pulsnet.58-60 Unlike PFGE however, MLVA requires an extensive genus and species-
specific survey and validation of candidate genes with tandem repeat regions exhibiting 
appropriate levels of variability.  To date MLVA has not been developed for sub-typing 
of S. pseudintermedius. 
spa typing is an older single locus technique and subset of MLVA developed by Frenay et 
al.; the sequence variation in a highly polymorphic region of the S. aureus protein A is 
measured and typed, and statistical software determines relatedness between 
isolates.61 Its primary advantage is that only one PCR and sequencing reaction are 
required to characterize each isolate.  The polymorphic region is classified by number of 
24bp repeats and point mutations.  Some hospitals use spa typing as their high 
throughput baseline MRSA typing modality, monitoring for unusual homogeneous 
spikes in spa types that might require PFGE or MLVA for finer characterization. Among 
its disadvantages include this need for verification by other methods, and the potential 
for mischaracterization of an isolate due to a recombination event that includes spa.62 
Within the last two years the spa locus has been characterized for S. pseudintermedius 
and used in conjunction with PFGE53 and MLST46 to illustrate clonality in large regional 
samples of MRSP.  This technique appears promising as a tool to gather information on 
sample sizes in the hundreds or thousands, and could be invaluable for an as yet 




Multilocus Sequence Typing 
 
The resolution provided by PFGE is more in step with the parsing of small differences 
between isolates.  On the other end of the sub-typing spectrum, for measurement of 
bacterial genomic variation through time and over great distances, MLST is the method 
of choice.63,64 MLST for S. aureus requires seven individual PCRs (400-500bp) and 
sequence analyses in the housekeeping genes: carbamate kinase (arcC), shikimate 
dehydrogenase (aroE), glycerol kinase (glp), guanylate kinase (gmk), phosphate 
acetyltransferase (pta), triosephosphate isomerase (tpi), and acetyl coenzyme A 
acetyltransferase (yqiL).65 S. aureus allelic profiles and STs are assigned by comparing 
sequence data for each locus to the MLST repository at http://saureus.mlst.net/.  
Variations between loci in different isolates are designated as numbered alleles.  A 
distinct sequence type is made up of a unique combination of arbitrarily numbered 
alleles, e.g. MRSA ST5 has the assigned allelic profile 1-4-1-4-12-1-10.  
Essentialness of gene function is the primary selection criteria for MLST loci.  All isolates 
of a species must have all loci.  The loci should be areas of genes that are not prone to 
recombination, and should exhibit an average rate of point mutation through time.  The 
Feil et al. phylogenetic analysis of MLST showed that S. aureus alleles are at least 15-fold 
more likely to change by point mutation than by recombination; indicating 
recombination at these sites is rare, that they are stable enough to maintain function, 
but not too conserved either.63 Sequence differences between isolates at just one locus 
indicate a closer phylogenetic relationship than isolates sharing three or fewer alleles. 
eBURST analysis is a graphical representation alleles shared between sequence types. 
The four loci MLST developed for SIG by Bannoehr et. al has been described previously 
in this review.  Of the seven gene loci used in the standard S. aureus MLST, only the pta 
locus is shared between the two methods.33 S. pseudintermedius MLST has proven 
valuable in the examination of isolates collected over large geographic areas and 
through many bacterial generations, enabling broader associations than can be made 
with other methods.  In the proceeding studies MLST will be the primary tool used for 





Quorum-sensing in S. pseudintermedius 
 
As one of the gene loci examined for sequence typing, the accessory gene regulator 
(agr) quorum-sensing locus D serves a dual purpose as both a molecular target and a 
phenotypic driver of species selection in a mixed species environment.  The agrD locus 
encodes auto-inducing peptides (AIP) capable of modulating virulence under stress and 
in the presence of competing bacteria.  These peptides are seven to nine amino acids in 
length, and are constitutively expressed and deposited into the surrounding 
environment.  Once a threshold density of AIP is reached in the immediate bacterial 
environment (wound, biofilm, lysosome, etc.) the expression of RNA III is triggered, and 
a cascade of virulence-enhancing genes is activated.  AIPs of one agr type have been 
shown to inhibit the RNA III expression and virulence of staphylococci with a different 
agr type.   The agr system is thought to have evolved along lines of speciation within the 
genus; the assumption being that dominant AIPs have the ability to inhibit the SOS 
response in other bacteria within the species, genus, and potentially across genus 
boundries.66,67 However, in the case of S. pseudintermedius the four elucidated AIP 
variants are shared with S. delphini, and S. intermedius.  This suggests that the SIG 
shares common quorum-sensing capacity that has been conserved in spite of species 
differentiation with tropism towards fairly distinct ecological niches. 
SIG isolates encode AIPs structurally different than those of S. aureus.  While a majority 
of staphylococcal quorum sensing research has focused on interaction among different 
types of S. aureus AIPs, some evidence exists that S. aureus AIP may also dampen S. 
pseudintermedius virulence expression.66 Little is known about AIP interaction among 
different S. pseudintermedius agr types. Recent evidence suggests that expression of 
methicillin resistance may be triggered by the RNA III-mediated SOS response.68 These 
findings suggest that staphylococcal quorum-sensing cross-reactivity may inhibit the 




At its inception the goal of this doctoral project was to clarify the population genetics of 
MRSP in the United States.  This is largely unexplored territory.  Prior to this work MLST 
had been performed on only five methicillin resistant isolates from the United States as 
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part of the broader SIG multi-country analysis33, but no in-depth analysis of a specific 
referral center population had yet been undertaken.  To that end a molecular 
characterization scheme focusing on both the whole genome and the mecA cassette 
was implemented as the foundational study for this project.  Methicillin-resistant and 
susceptible isolates from the UTCVM collection were analyzed using mecA cassette 
sequencing and typing, PFGE, and MLST.  Our key findings (Chapter 2) are that the 
spread of methicillin-resistance within S. pseudintermedius is clonal (vertical), and that 
the southeastern US clone bears a cassette type similar to that of a Taiwanese MRSA 
lineage and wholly different than that of the European clonal MRSP. 
The next step was to capitalize on this population genetic information.  By segregating 
isolates according to clonal lineage, applying an external stimulus, and analyzing mecA 
expression as a response variable, the effect of genotype was correlated with antibiotic 
resistance behavior.  Our external stimuli (Chapter 3) include oxacillin over different 
lengths of time and different concentrations, as well as quorum-sensing AIPs. 
The problem as well as the study of methicillin-resistance in S. pseudintermedius is 
relatively new.  Defining the movement and activity of resistance genes and the isolates 
that carry them has both intrinsic and clinical value.  We hypothesize that the expansion 
of MRSP is proceeding in a clonal manner, analogous to the early expansion of MRSA.  
During this nascent phase of expansion there may be as few as two predominant 
regional clones.  The over-arching theme for this work is that once characterized, the 
clonality of methicillin-resistant staphylococcal lineages can be exploited by linking 
genotype with expression characteristics.  Clonality allows the molecular researcher to 
inform the clinician of conserved characteristics.  These discovered characteristics will in 
turn inform decisions on antibiotic therapy choice and infection control strategies.   
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Methicillin resistance encoded by the mecA gene is increasingly observed in 
Staphylococcus pseudintermedius. Little is known about the population genetics of 
veterinary staphylococci bearing methicillin resistance. The aim of this study was to 
determine the relatedness of resistant bacteria and to compare them with methicillin-
susceptible isolates. Multilocus sequence typing (MLST) and pulsed-field gel 
electrophoresis (PFGE) fragment profiling were performed on methicillin-resistant S. 
pseudintermedius (MRSP) and methicillin-susceptible S. pseudintermedius (MSSP) 
isolates obtained from canine samples submitted to the veterinary teaching hospital 
bacteriology service between 2006 and 2008. Multilocus sequence typing detected 20 
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different sequence types, 16 of which were not previously described. Methicillin-
resistant isolates were predominantly ST68, possessed the Staphylococcus aureus-
associated staphylococcal chromosomal cassette mec (SCCmec) type VT and fell within 
the largest PFGE cluster; whereas methicillin-susceptible strains were more genetically 
diverse. This suggests that most methicillin resistance within the population of isolates 





Coagulase-positive hemolytic Staphylococcus species, particularly S. pseudintermedius, 
are associated with clinically important infections in dogs. The prevalence of MRSP in 
dogs is rising. Prior to 1999 reported frequencies of MRSP isolates from dogs were low 
(<5%); in several surveys from the 1980s, all veterinary staphylococcal isolates tested 
were susceptible to methicillin.5,36,37 An increasing number of multidrug-resistant 
isolates from dogs have been associated with MRSP.8,35  
Little is known about the population genetics of MRSP. Epidemic MRSA lineages have 
emerged through horizontal transfer of SCCmec into successful methicillin-susceptible 
lineages. Once established, MRSA clonal complexes typically dominate specific 
geographic regions.69 It is likely that this has occurred with MRSP, and that S. 
pseudintermedius gained SCCmec through horizontal transmission within recent 
history.33 
The purpose of this study was to use standard MLST, PFGE, and SCCmec typing 
techniques to explore relationships among a collection of geographically linked, MRSP 




Materials and Methods 
 
Bacterial strain selection 
 
S. pseudintermedius isolates were obtained from clinical samples submitted to the 
University of Tennessee College of Veterinary Medicine Clinical Bacteriology Laboratory.  
A total of 60 non-duplicate isolates from dogs were arbitrarily selected from nine 
groups, and then were sorted by year of isolation and by presumptive categories of 
relative in vitro susceptibility to oxacillin.  Samples included 20 from 2006, 21 from 2007, 
and 19 from 2008.  Isolates with oxacillin zone diameters equal to or less than 10 mm 
were categorized as high-level-resistant (n=19), isolates with zone diameters from 11 to 
17 mm were categorized as low-level-resistant (n=21) and isolates with zone diameters 
equal to or greater than 18mm were categorized susceptible (n=20).70 Each group 
contained six to eight isolates. Bacterial isolation and identification procedures were 
those routinely used in the laboratory as previously described.8 Isolates phenotypically 
identified as “S. intermedius” were presumed to be S. pseudintermedius.  Species 
identity of S. pseudintermedius was confirmed by partial 16S rRNA and pta gene 
sequencing associated with the MLST process (Bannoehr et al., 2007).  The type strain of 
S. intermedius isolated from a pigeon (ATCC 29663) and S. pseudintermedius (ATCC 
51874, isolated from a dog and originally designated S. intermedius) served as reference 




Isolates were grown on blood agar plates overnight at 37°C and bacteria derived from a 
single colony were suspended in 0.5 ml of TE buffer mixed with an equal volume of glass 






SCCmec typing and characterization 
 
Multiplex PCR designed for characterization of SCCmec types I-V in S. aureus was used 
to characterize all MRSP cassette types.43 A representative ST68 was chosen for full 
cassette sequencing using a primer walking strategy.  Sequences were obtained from 
PCR products at the University of Tennessee Molecular Biology Resource Facility. 
Overlapping contiguous sequences were aligned using DNA analysis software (Lasergene 
Sequence Manager).  PCR primers for the detection of the ccrC2 sequence in SCCmec 
type VT were used to confirm the similarity of the type V cassettes associated with ST68 
isolates.71 
 
Multilocus Sequence Typing 
 
Oligonucleotide primers specific for tuf, mecA, 16s rRNA, cpn60, pta and agrD genes 
were designed in previous studies.33,72 PCR was performed as previously described.33 
PCR products of expected sizes were treated to destroy single-stranded DNA (ExoSap-IT, 
USB Corp., Cleveland, OH) and submitted to the University of Tennessee Molecular 
Biology Resource Facility for DNA sequencing.  PCR primers were used for direct DNA 
sequencing of PCR amplification products. STs were assigned using the method 
established by Bannoehr et al.  Briefly, this involved matching pta, cpn60, tuf, and agrD 
sequences determined from study isolates with corresponding reference sequences 
available in GenBank.  Designations for each allele correspond to a code used to assign 
ST.  For alleles that were not previously reported, new STs were assigned beginning 
sequentially and following the previous designations. 
 
Pulsed-field Gel Electrophoresis 
 
Pulsed-field gel electrophoresis (PFGE) was performed using the protocol described by 
McDougal et al. with minor modifications.52  Briefly, a single colony from each 
catalogued isolate was grown aerobically on a blood agar plate for 24 hours at 37°C.  
From the plate a cell suspension in saline was made to a reading of 0.50 using the 
MicroScan turbidity meter, (Dade Behring Inc., Deerfield, IL).  Plugs were formed in 
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disposable ~ 100 μl molds by mixing equal amounts of cell suspension with 1.2% 
SeaKem Gold agarose (FMC, Rockland, Maine).  Formed plugs where incubated in a 
solution of TE buffer (2.8 ml, 10 mM Tris HCl, 1 mM EDTA *pH 8+), Lysozyme (200 μl, 10 
mg/ml) and Lysostaphin (20 μl, 10 mg/ml) for two hours at 37°C.  The previous solution 
was poured off.  The plugs were then incubated in 5 ml of cell lysis buffer (1M Tris HCL, 
0.5M EDTA, 10% Sarcosyl solution, Sterile Type 1 water) and 10U proteinase K at 54°C 
for two hours in a shaking water bath.  Plugs were washed twice with Type 1 water for 5 
minutes and four times with TE buffer for 15 minutes each. All washes took place in the 
54°C shaking water bath.  Plugs were cut in half and digested using 2 μl BSA, 20 μl of 
buffer 4 New England BioLabs (NEB, Ipswich, MA), 40U SmaI (NEB) and 176 μl of Type 1 
water per section. Digestion was achieved over a minimum of two hours in a 25°C water 
bath. Restriction fragments were separated by PFGE using a CHEF Mapper (Bio-Rad 
Laboratories, Hercules, CA). Running conditions consisted of 6.0 V/cm, optimized for 
separation of 30 kb low molecular weight to 600 kb high molecular weight fragments, 
and 40 second initial switch time and 45 second final switch time for 18 hours. Isolates 
unable to elicit a distinct band pattern with SmaI were restricted with ApaI using the 
same protocol. 
Gels were stained with ethidium bromide, destained in deionized water and the images 
were digitally captured using a GelDoc 2000 UV transilluminator and Quantity One 
software (Bio-Rad Laboratories, Hercules, CA).  The Salmonella Braenderup H9812 
global standard was used for gel normalization using BioNumerics software (Applied 
Maths, Sint-Martens-Latem, Belgium) and banding patterns were compared in the 
normalized view using PulseNet E. coli scripts.  PFGE DNA fingerprint types were 




SCCmec typing and characterization 
 
Identical mecA gene sequences were obtained from all methicillin-resistant strains, 
matching S. pseudintermedius (accession no. AM 904732) and S. aureus (accession no. 
EU 790490).   Thirty-seven of 38 MRSP SCCmec types characterized via multiplex PCR43 
corresponded with S. aureus type V.  Thirty-seven of 38 MRSP SCCmec types 
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characterized via ccrC2 PCR71 corresponded with S. aureus SCCmec type VT.  A single 
MRSP isolate was untypeable by either method. 
Sequence of a representative type V S. pseudintermedius cassette (GenBank accession 
no. FJ544922.1) was homologous, with the exception of one deleted section of a gene, 
to SCCmec type VT (accession no. AB462393) first described in a community-associated 
methicillin-resistant S. aureus (CA-MRSA) from Taiwan.74 
 
Multilocus Sequence Typing 
 
A total of 600 fragment sequences including forward and reverse reactions, 
representing five genes (16S rRNA, pta, tuf, cpn60 and agrD) from 60 strains, were 
analyzed. 16S rRNA gene sequences were identical among all isolates in this study and 
matched those reported for S. pseudintermedius (accession no. EU157264).  
Thirty-seven of 38 methicillin-resistant isolates belonged to ST68, while a single 
methicillin-resistant isolate, from 2007 and phenotypically classified as low-level 
resistant, had a novel ST pattern (TABLE 2).  No apparent association was found 
between oxacillin disk zone diameter for methicillin-resistant isolates and ST.  Fifteen of 
the novel sequence types were detected among 19 of the 22 methicillin-susceptible 
strains examined. 
The pta sequences examined had five different alleles (TABLE 1). The sequences of four 
alleles were identical to S. pseudintermedius pta sequences previously reported.33 A 
novel pta sequence, representing a fifth allele, with a single nucleotide difference, was 
identified (accession no. FJ170820).  
Eight variable sites were detected in cpn60 sequences and were identical to those 
reported previously.33 A novel cpn60 sequence was found in the same isolate that 
contained a novel pta sequence (accession no. FJ170819).  
One variable site occurred in tuf sequences with two alleles. These sequences were 
identical to S. pseudintermedius sequences reported previously.33 
agrD sequencing revealed the presence of the four previously described alleles and 
known agrD (auto-inducing peptide) types.33 MRSP ST68 was type IV; as were eight of  
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the MSSP isolates.  Type ІІІ was found in six of 20 MSSP isolates, as well as in the novel 
MRSP ST105.  Type II was found in seven of 20 MSSP isolates.  Type I was found in only 
one novel susceptible strain.  
 
Pulsed-field Gel Electrophoresis 
 
A dendrogram of percent similarity, calculated with Dice coefficients revealed a single 
major cluster of methicillin-resistant isolates containing all 37 that were ST 68 (FIGURE 
1).  Within the pulsed-field cluster that contained ST 68, 22 subtypes were identified 
with 79.7% similarity.  Three ST68 isolates, representing two subtypes, were positioned 
outside the 80% cutoff for close relatedness by the Tenover criteria.73 
 
The single MRSP isolate with the novel sequence type ST105, and containing an SCCmec 
type other than MRSA SCCmec type VT, exhibited a pulsed-field pattern unrelated to any 
other isolates tested. 
All methicillin-susceptible isolates exhibited unique pulsed-field patterns.  Three 
susceptible groups were closely related – one group with three isolates, two groups with 
two isolates each.  All isolates within >80% similarity groupings, other than the group 
containing all ST68 isolates, had distinct sequence types.  
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FIGURE 2.1. Dendrogram based on pulsed-field gel electrophoresis analysis of 60 S. pseudintermedius. 






MLST and PFGE are both highly discriminatory methods for characterizing bacterial 
isolates.52,65 In contrast to single locus classification systems, whole genome or 
multilocus identification methods provide more clarity concerning bacterial relatedness 
and can be applied to both susceptible and resistant strains.  MLST was used in a multi-
country survey to determine the population genetic structure of S. pseudintermedius; 
however, in that study only five methicillin-resistant samples from the United States 
were included.33 Other recent surveys using PFGE have demonstrated relatedness 
amongst MRSP isolates in small sample sizes from specific geographic regions.53,75  
 Results from our study add strength to the horizontal transmission and geographic 
clonal dissemination model of methicillin-resistant staphylococci.69 Our most notable 
finding is that 37 of 38 methicillin-resistant isolates in this regional sampling were of a 
single sequence type, ST68, and demonstrated relatedness in pulsed-field type.  This 
finding parallels the Bannoehr European sample wherein seven methicillin-resistant 
isolates from dogs with clinical infections in Germany and Sweden were also from a 
single clone, ST71, while a single canine commensal isolate from Sweden was of a 
different clonal group, ST69.33 
The 37 ST68 isolates appeared to carry a type V cassette when tested with the S. aureus 
multiplex PCR typing described by Zhang et al., but DNA sequencing of the cassette 
revealed that it was a truncated version of SCCmec type VT.
74 This cassette was first 
reported in a successful multidrug-resistant CA-MRSA lineage from Taiwan, and has 
recently been reclassified as SCCmec type VII.71 SCCmec types II, III and V were 
previously described in S. pseudintermedius using multiplex PCR procedures used in the 
present study, and the complete cassette sequence from two isolates that were 
characterized as having type III cassettes by the multiplex PCR method revealed a new 
hybrid sequence that has been called type II-III.47 The SCCmec cassette associated with 
the ST105 isolate has not yet been characterized, as this cassette is untypeable using the 
methods employed for this study.  However, the presence of mecA in ST105 has been 
confirmed using PCR, and the ST105-associated cassette has been differentiated from 
the ST 68-associated cassette by applying primers used for type V sequencing.  The 
circumstances and mechanism by which the ST68 S. pseudintermedius lineage in the 
present study acquired a cassette associated with a disease-causing human S. aureus 
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lineage are unknown.  The finding implies, however, that inter-species transfer of 
antibiotic resistance between human and canine pathogens may have occurred. 
A single methicillin-resistant isolate with a different and novel ST and pulsed-field type 
was found – ST105.  Only five MRSP sequence types have been described – STs 29, 68, 
69, 70 and 71.33 ST 105 differed from ST 68 at three alleles, indicating a distant 
phylogenetic relationship.  This genetic dissimilarity supports the independent 
acquisition of mecA by each lineage.33 Sequence type 105 may represent an emerging 
MRSP lineage, or it may be a transient cassette carrier that will fail to successfully 
compete with the predominant ST68.  Collectively these data indicate that clonal 
expansion, regional selection and maintenance of the more successful clone have 
occurred. 
Only three previously reported MSSP sequence types, STs 15, 17 and 19, were identified 
from one isolate each.  Sixteen novel sequence types were identified among clinical 
isolates of S. pseudintermedius from dogs; all but one were from methicillin-susceptible 
isolates.  Among methicillin-susceptible strains in our study 19 of 22 (86%) belonged to 
novel STs and all had distinct pulsed-field patterns.  This broad range of clonal diversity 
amongst MSSP contrasts with the limited number of MRSP lineages seen in the United 
States and Europe, where ST68 and ST71 predominate respectively.33 
It is not known if the apparent tendency of antibiotic resistance cassettes to remain in 
so few lineages is due to the rarity and relative difficulty of cassette transfer, or is a 
function of the ability of an MSSP lineage to successfully incorporate the mobile genetic 
element into its genome. Based upon the variety of MSSP isolates observed, this 
question warrants further investigation.   
In this study, we report an association between ST 68, PFGE type and SCCmec type VT in 
contemporary clinical isolates of S. pseudintermedius from dogs in the southeastern 
United States.  The known genetic diversity among canine isolates of S. 
pseudintermedius was increased by the discovery of 16 novel sequence types and a 
strain that contained novel sequences for both pta and cpn60 genes.  Regional, national 
and global sharing of molecular surveillance data generated for MRSP strains through 
the use of techniques such as single and multi-locus gene sequencing and PFGE will help 
determine the epidemiological significance and patterns of spread for these newly 
emerging strains.  
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Regional clones of methicillin-resistant Staphylococcus pseudintermedius (MRSP) 
affecting veterinary clinical practice have recently been identified in Europe and North 
America – multilocus sequence types (MLST) 71 and 68 respectively.  One notable 
difference between the two clones is a deletion in the mecI/mecR1 regulatory apparatus 
of the staphylococcal chromosome cassette (SCCmec) carried by ST68.  This deletion in 
analogous methicillin-resistant Staphylococcus aureus (MRSA) results in more 
responsive and greater expression of the mecA encoded penicillin-binding protein 2a, a 
characteristic associated with community-acquired MRSA lineages.  The aim of this 
study was to characterize mec and bla regulatory apparatuses in MRSP.  Seventeen wild-
type S. pseudintermedius isolates representing nine methicillin-resistant lineages were 
screened via PCR for the presence of the repressors blaI and mecI and sensors blaR1 and 
mecR1.  The bla and mec operons for each isolate were sequenced and compared for 
homology between the repressor open-reading frames (ORF), sensor ORFs, and mecA 
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promoter regions.  A real-time reverse transcriptase PCR expression assay was 
developed, validated and applied to nine isolates determining the effect of low-level 
oxacillin induction and quorum-sensing reporter RNAIII on mecA transcript production.  
Comparisons of the induction of mecA expression were made between isolates with a 
full regulatory complement (mecI/mecR1 and blaI/blaR1) and those with truncated 




Staphylococcus pseudintermedius on dogs is analogous to S. aureus on humans, acting 
as both normal flora and opportunistic pathogen.  It is the primary cause of pyoderma, 
the most common dermatologic disease seen in dogs, and is also frequently associated 
with wound, urinary tract and surgical site infections.4 The first finding of S. 
pseudintermedius bearing the mecA methicillin resistance gene occurred in 1999.5 In the 
decade since its discovery, methicillin-resistant S. pseudintermedius (MRSP) has become 
increasingly common, reaching prevalence as high as 30% in studies of referral center 
isolates.6,35,76  
Recent multilocus sequence typing (MLST) studies have established geographic clonal 
emergence of two MRSP lineages.33,45,77,46 Sequence type 71 predominates in Europe, 
bears the hybrid resistance cassette SCCmec II-III, and has acquired resistance to all 
clinically useful veterinary antimicrobial drugs expect lincosamides.77,47 Whereas ST68 is 
the most common MRSP sequence type in the United States and Canada, bears SCCmec 
VT, and has acquired resistance to all clinically useful veterinary antimicrobial drugs 
except chloramphenicol.45,77   
As is the case with MRSA, methicillin resistance in S. pseudintermedius results most 
commonly from the acquisition of the mecA gene encoding penicillin-binding protein 2a 
(PBP2a).  PBP2a contains an altered beta-lactam binding site, preventing antibiotics of 
that class from disrupting gram-positive cell wall metabolism.  In addition to synthetic 
beta-lactam resistance mediated by mecA, all isolates characterized as ST68 and ST71 
have thus far also demonstrated penicillin resistance through blaZ-encoded beta-
lactamase.33,45,77,46 
The controlling mechanisms for bla and mec systems are different from other bacterial 
signal transduction pathways in that they lack a kinase-based system for signal 
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transduction.78 Instead they are modulated by two-component systems consisting of the 
analogous repressors mecI and blaI and sensors mecR1 and blaR1 respectively.   BlaR1 
and MecR1 represent transmembrane spanning and signal transducing proteins.  
Acylation of BlaR1/MecR1 subsequent to external interaction with beta-lactam 
antibiotics is followed by their autoproteolytic cleavage on the cytoplasmic side of the 
cell membrane.   This separated intracellular portion of BlaR1/MecR1 travels to the 
bacterial chromosome and removes its cognate repressor BlaI/MecI via proteolysis.  
Once the repressor dissociates from its promoter-region binding site, transcription of 
the blaZ/blaR1/blaI and mecA/mecR1/mecI genes begins.   The structure and function of 
MecI and BlaI are similar but not identical; they share approximately 60 percent 
sequence homology.79,80 The repressors can act interchangeably, binding to the 
promoter-operator region of either the blaZ or mecA operon.  However, mecA induction 
occurs only through the cognate sensor; the intracellular peptidase portion of 
transmembrane BlaR1 only has activity on BlaI, and MecR1 only cleaves MecI.81   
The mec promoter region consists of  ~100 nucleotides situated between the mecA and 
mecR1 open reading frames.  The mec operator is a subset of the promoter region and is 
a 30 bp palindrome covering mecA -10 and mecR1 -35 promoter sequences.  Within the 
palindrome lies two 4 bp inverted repeats (TACA/TGTA) that serve as binding motifs for 
the repressors MecI and BlaI.79,82 Others have shown that mutations within this 
operator region can affect the ability of the repressors to bind appropriately, and 
thereby account for differences in mecA expression.83  
In MRSA it has been demonstrated that mecI/mecR1 and blaI/blarR1 configuration has a 
significant impact on the speed and character of mecA induction.  While a majority of 
epidemic strains are blaZ positive with functional blaI/blaR1 elements, many have 
deletions of mecI and varying levels of truncation in mecR1; the completeness of the 
mecA operon has become a defining characteristic of MRSA SCCmec type.  Clinical MRSA 
isolates as well as transformed laboratory strains with only mecI/mecR1 induced mecA 
expression more slowly than those with complete blaI/blaR1 and without functional 
mecI/mecR1.  Those isolates with both regulatory apparatuses, with both MecI and BlaI 
available for promoter binding, appear to be even more tightly controlled.84,85 
Methicillin resistant staphylococcal isolates cured of their SCCmec have improved 
growth rates relative to their mecA containing counterparts.86 This discovery and the 
presence of some level of bla and mec regulatory apparatus in all successful and widely-
disseminated methicillin-resistant lineages suggests a metabolic cost is associated with 
unregulated expression of mecA.  The exact benefit derived from differing levels of 
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mecA control is unclear.  However, a recent historical examination of antibiotic 
resistance in S. aureus by Chambers and DeLeo demonstrates four waves in MRSA 
evolution beginning with blaZ in response to penicillin therapy, followed by three mecA 
acquisitions with differing levels of mecA control.  The initial Iberian clone and 
subsequent healthcare-associated MRSA lineages bearing SCCmec types II and III have 
functioning mecI and mecR1; whereas more recent community-associated MRSA bear 
cassettes with mecI deletions and rely on blaI/blaR1 to regulate mecA expression.87-89 
In addition to mec-specific regulatory genes, staphylococci also carry the more 
generalized accessory gene regulator (agr) complex, which produces one of four 
potential quorum-sensing auto-inducing peptides (AIP) characteristic of its lineage.  The 
peptides are seven to nine amino acids in length, and are constitutively expressed and 
deposited into the surrounding environment by the bacteria.  Once a threshold density 
of AIP is reached, the expression of RNAIII is triggered, and a cascade of potential 
virulence-enhancing genes is activated.66 Recent expression studies with MRSA have 
suggested that mecA may fall under the broader control of agr.68 The agr locus of 
MRS(P)I has been described67, but its relationship to mecA has yet to be investigated. 
The emergence of MRSP is recent relative to that of MRSA and thus far restricted to two 
known geographic clones bearing distinct cassette types.  These SCCmec types differ in 
the mecI/mecR1 regulatory apparatus of mecA, and are analogous with the two types of 
cassette structures found in HA and CA-MRSA.  Here we inventory the 
mecA/mecI/mecR1, blaZ/blaI/blaR1, and mecA promoter region status of both major 
and minor MRSP lineages and apply a real-time RT-PCR mecA expression assay to 
correlate regulatory gene presence or absence with speed and abundance of transcript 
production.   
 
Materials and Methods 
 
Bacterial Isolate Selection and Identification 
 
S. pseudintermedius isolates were obtained from clinical samples submitted to the 
University of Tennessee College of Veterinary Medicine Clinical Bacteriology Laboratory 
as well as from European and North American collaborators through previous clonality 
studies.45,77 A total of 17 non-duplicate isolates from dogs were selected representing 
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nine MLST lineages associated with methicillin resistance as an initial pool to screen for 
blaI/blaR1 and mecI/mecR1 variation.  Bacterial isolation and identification procedures 
were those routinely used in the laboratory as previously described.8 Isolates 
phenotypically identified as ‘‘S. intermedius’’ were presumed to be S. pseudintermedius.  
Multilocus sequence typing provided definitive species identity of S. pseudintermedius 
with partial 16S rRNA and pta gene sequencing. The type strain of S. intermedius 
isolated from a pigeon (ATCC 29663) and S. pseudintermedius (ATCC 51874, isolated 





Isolates were grown on blood agar plates overnight at 37°C and bacteria derived from a 
single colony were suspended in 0.5 ml of TE buffer mixed with an equal volume of glass 
beads and vortexed for ten minutes.  Supernantant in the centrifuged cell lysate was 
used as template DNA for traditional PCR amplification of mec and bla regulatory genes. 
 
PCR Primers and Conditions 
 
Olignucleotide primers specific for S. pseudintermedius mecA promoter and blaI/blaR1 
were based upon MRSP SCCmec type V cassette (GenBank accession no. FJ544922.1) 
and unpublished ST68 genomic data respectively (TABLE 3.1), and designed using IDT 
SciTools application (Integrated DNA Technologies, Coralville, IA).90 Primers for 
mecI/mecR1 were adapted from Hiramatsu et al.91 Primers for RNAIII were adapted 
from Sung et al.67 Conventional PCR was performed using the following parameters: 95º 
for 90 seconds followed by 35 cycles of 55° for 30 seconds, 68º for 120 seconds, and 94º 











PCR products of expected sizes were treated to destroy single-stranded DNA (ExoSap-IT, 
USB Corp., Cleveland, OH) and submitted to the University of Tennessee Molecular 
Biology Resource Facility for DNA sequencing.  PCR primers were used for direct DNA 
sequencing of PCR amplification products.  Open reading frames for blaI, blaR1, mecI, 
mecR1 and mecA promoter were compared between isolates using Lasergene® SeqMan 
Pro software (DNASTAR, Inc., Madison, WI). 
 
MLST and PFGE 
 
Genetic diversity of S. pseudintermedius was determined by MLST of five genes (16S 
rDNA, tuf, cpn60, pta and agrD) and by SmaI-PFGE as previously described.33,45 MLST 
sequences were compared with allele sequences present in the NCBI nucleotide 
database in order to determine the allele number.  Sequence type numbers were 
assigned using the key table for MLST typing of S. intermedius group isolates.  New 
sequence types were assigned by the curator, Vincent Perreten 
(vincent.perreten@vbi.unibe.ch).77 
 
Bacterial Growth and RNA Extraction – Time Point mecA Expression Assay 
 
For each isolate a 5 ml vial of BBL™ Trypticase™ soy broth (TSB, Becton, Dickinson and 
Co., Sparks, MD) was inoculated with a single colony grown on blood agar and then 
incubated overnight at 37°C and 225 rpm.  Fifty microliters of overnight growth was 
used to inoculate four additional 5 ml soy broth vials, which were subsequently 
incubated at 37°C and 225 rpm for four hours.  Oxacillin (Sigma Aldrich, St. Louis , MO) 
was added to a single vial at four, two, and one hours prior to RNA extraction.  The 
oxacillin concentration was 0.01 µg/ml for all induction vials; this concentration was 
chosen because in preliminary testing it represented the minimum amount at which the 
type strain ST68 (06 3228) reproducibly increased mecA expression greater than five-
fold over baseline.  One of the four vials was incubated without oxacillin induction to 
serve as the baseline for mecA expression. 
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Following four hours of growth RNA was extracted using UltraClean™ Microbial RNA 
Isolation Kit (MO BIO Laboratories, Carlsbad, CA).  Contaminating DNA was removed 
using TURBO DNA-free™ DNase (Ambion, Inc., Austin, TX).  The resulting RNA template 
was stored in aliquots suspended in DNase RNase free water at -80.0°C. 
 
Bacterial Growth and RNA Extraction – Oxacillin Curve mecA Expression Assay 
 
For each isolate a 5 ml vial of BBL™ TSB (Becton, Dickinson and Co., Sparks, MD) was 
inoculated with a single colony from growth on blood agar and was then incubated 
overnight at 37°C and 225 rpm.  Fifty microliters of overnight growth was used to 
inoculate seven additional 5 ml soy broth vials, which were incubated at 37°C and 225 
rpm for four hours.  Oxacillin (Sigma Aldrich, St. Louis , MO) was added to six vials in a 
fivefold dilution series at concentrations 0.0016, 0.0080, 0.0400, 0.2000, 1.0000 and 
5.0000 µg/ml.  One of seven vials was incubated without oxacillin induction to serve as a 
mecA expression baseline. 
Following four hours of growth RNA was extracted using UltraClean™ Microbial RNA 
Isolation Kit (MO BIO Laboratories, Carlsbad, CA).  Contaminating DNA was removed 
using TURBO DNA-free™ DNase (Ambion, Inc., Austin, TX).  Resulting RNA template was 
stored in aliquots suspended in DNase RNase free water at -80.0°C. 
 
Realtime RT-PCR – Measurement of mecA Induction and Copy Number 
 
Primers and probes (TABLE 3.2) for target mecA and endogenous control 16S were 
designed using Primer Express® software and constructed as custom TaqMan® Gene 
Expression Assays (Applied Biosystems, Foster City, CA).  Applied Biosystems reagents 
TaqMan® 2X Universal PCR Master Mix and Multiscribe™ Reverse Transcriptase were 
used in a 10 µl one-step RT-PCR protocol in the following amounts per well: 5.00 µl Taq 
polymerase, 2.75 µl water, 1.50 µl template RNA, 0.50 µl primer and probe mix, and 
0.25 µl reverse transcriptase.  Each sample was analyzed in triplicate.  Template RNA 
was diluted either 1 to 100 or 1 to 1000.  All time point or differing oxacillin 
concentration samples for each isolate were analyzed together in one run per isolate on 


















probe 5'-CTGTTTCTGCGATAAGTTT-3'  




CA).  Thermocycler parameters were as follows:  48°C for 30 minutes, 95°C for 10 
minutes, 40 cycles: 95°C for 15 seconds and 60°C for 1 minute. 
The mecA mRNA for standard curve analysis was produced by adding a T7 promoter to 
the sequence of the mecA forward primer utilized in the real-time assay (TABLE 3.2).  
This primer coupled with the reverse primer from the real-time assay was applied to 
genomic DNA of 06 3228 under the following thermo-cycling conditions: 95º for 90 
seconds followed by 35 cycles of 55º for 30 seconds, 68º for 120 seconds, and 94º for 30 
seconds.  The resulting T7 mecA DNA template was electrophoresed on an 0.8% agarose 
gel.  The single band 117 bp product was excised and extracted (QIAquick® Gel 
Extraction Kit, Germantown, MD).  Following manufacturer’s recommendations for DNA 
<500 bp in length, 1.0 µg served as template in a 16 hour transcription reaction 
(MEGAscript® T7, Ambion Inc., Austin, TX).  The 97 bp RNA product was treated with 4 U 
TURBO DNase (Ambion Inc., Austin, TX) at 37ºC for 30 min, and filtered to remove all 
non-RNA elements (MEGAclear™, Ambion Inc., Austin, TX).  The copy number per µl was 
calculated using µg/ml measurements from a NanoDrop 3300 fluorospectrometer 
(ThermoScientific Inc., Wilmington, DE).  The transcripts were used to create standard 
curves for absolute quantitation of mecA mRNA transcripts isolated from the samples.  
The numbers of RNA copies were estimated based on the molecular weights of the RNA 
standards and the RNA concentrations.  Ten-fold serial dilutions were prepared, and 
aliquots of each dilution were stored at –80°C and used only once.  
 
The efficiency of the real-time RT-PCR assay to amplify the mecA standard mRNA was 
evaluated with the equation:  Efficiency = [10(–1/slope)] – 1.92 Slope is a value derived from 
the constructed standard curves.   To insure equal amplification efficiency in tested 
isolates, four ten-fold serial dilutions of RNA extracted from wild-type MRSP were tested 
against the standard curve.  The efficiencies were comparable.  Quantitiation of mecA 
copy number was calculated by transforming Ct values to the relative number of RNA 
molecules. The quantity of cDNA for each experimental gene was normalized to the 






Estimation of 16S Endogenous Control Copy Number 
 
Multiple 16S genes appear in the bacterial chromosome of S. aureus, usually ranging 
from six to eight copies.94 To insure that mecA transcript measurement was not 
compromised by significant disparities in 16S copy number between S. 
pseudintermedius sequence types, comparison of 16S DNA relative to that of single copy 
mecA was made using real-time PCR.   
Genomic DNA from one isolate each representing STs 68, 71, 73, and 116 was extracted 
using UltraClean™ Microbial DNA Isolation Kit (Mo Bio Laboratories, Inc., Carlsbad, CA).  
The purified DNA amount was measured and adjusted to equal µg/ml concentrations.  
Real-time PCR was performed as previously described without reverse transcriptase 
using 16S rRNA and mecA primers and probes.  Based upon the assumptions that both 
primer sets are equally efficient (achieved with validation for ∆∆Ct mecA expression 
assay) and that mecA is represented in the genome as a single copy, 16S rRNA Ct values 
arising before that of mecA indicate that multiple 16s genomic copies are present.  Fold 
change calculations can then show 16s copy number relative to that of mecA. 
 
RNAIII Expression in Conjunction with mecA Expression 
 
For each isolate a 5 ml vial of BBL™ TSB (Becton, Dickinson and Co., Sparks, MD) was 
inoculated with a single colony from growth on blood agar and was then incubated 
overnight at 37°C and 225 rpm.  Fifty microliters of overnight growth was used to 
inoculate five additional 5 ml soy broth vials, which were incubated at 37°C and 225 rpm 
for one, three, five, seven, and nine hours.  RNA extraction and realtime RT-PCR was 
performed as previously described using mecA and RNAIII specific primers and probes.  
Each reaction was performed in triplicate with one primer set per well.  ∆∆Ct fold-






A mixed model ANOVA (SAS, version 9.2, SAS Institute Inc, Cary, NC) was used to 
estimate the effect of sequence type (68 verses 71) and time on inverse log of mecA 
expression.  Isolate, sequence type and time were modeled as class variables and isolate 
was included as a random factor in the model.  Independent variables sequence type, 
time and the interaction of sequence type and time were evaluated for an effect on the 
dependent variable log of mecA copy number.  A second and similar model was used to 
assess the effect of blaI regulation alone verses functional mecI regulation, time and the 
interaction of blaI and mecI status on the inverse log of mecA copy number.  In the 
second model isolate, gene status (blaI vs. mecI) and time were included as class 
variables.  A multiple range test according to the method of Tukey was used to adjust 
for multiple comparisons in both models.  The fit of the both models to the data was 
evaluated by assessing the degree to which the residuals from the models fit a normal 
distribution using the Shapiro-Wilk test statistic.  An a priori adjusted p-value of < 0.05 




Screening for mecA, mecI, mecR1, blaZ, blaI, and blaR1 Initial mecA Expression Assay 
 
Twelve isolates representing nine sequence types comprised the initial mec and bla 
regulatory element survey of MRSP isolates (TABLE 3.3).  All were phenotypically 
methicillin resistant and confirmed mecA positive.  All but one isolate (ST73) were 
phenotypically beta-lactamase positive and contained blaZ, blaI and blaR1 elements.  
Sequence types 71 and 73 were the only MRSP backgrounds that screened positive for 
the repressor mecI.  The two ST71 isolates (one European and one North American) 
contained both repressors mecI and blaI.  No American isolates other than NA18 (ST71) 
had a complete mecI sequence. 
The initial twelve isolates chosen for mec and bla regulatory element detection were 
grown with and without 0.01 µg/ml oxacillin for four hours and the relative level of 
mecA transcript production was measured by realtime RT-PCR using the ∆∆Ct method 
(FIGURE 3.1).  Error bars indicate the standard error of the mean and relative 





TABLE 3.3.  Isolates used in study – presence/absence of mec and bla elements.  Shaded rows represent isolates that were further characterized by time 




Those isolates screening positive for blaI only (represented by North American STs 26, 
68, 69, 105, 116, and 118) increased mecA expression to a greater extent than the ST71s 
containing both mecI and blaI.  Sequence type 73 bearing mecI alone increased mecA 
expression at four hours to a level similar to that of the blaI-only isolates. 
 
Sequence Type Selection for Further Analyses 
 
Based upon the initial mecA expression assay and the presence or absence of mec and 
bla elements, STs 73 and 116 were selected to contrast the regulatory apparatuses of 
the predominant geographic clones ST68 (North America) and ST71 (Europe).  Sequence 
type 73 lacks a bla operon but has a complete mec operon resulting in a -blaI/-blaR1 
+mecI/+mecR1 configuration with regard to mecA expression control.  Whereas ST68 
has +blaI/+blaR1 -mecI/mutmecR1 (absent mecI and mutation/truncation of mecR1) and 
ST71 has both complete repressor/sensor systems in +blaI/+blaR1 +mecI/+mecR1.  
Sequence type 116 was chosen because the original blaI 1 forward and reverse primers 
(TABLE 3.1) were unable to elicit a PCR product.  A region internal to the previous blaI 
target was amplified using blaI 2 forward and reverse primers.  Sequence type 116 blaI 
genomic sequence compared with that of STs 68 and 71 had multiple nucleotide and 
translational dissimilarities (FIGURE 3.2a).  Therefore ST116 was classified as 
mutblaI/+blaR1 -mecI/+mecR1 (the mutation designation for blaI is relative to that of STs 
68 and 71). 
Sequence types 73 and 116 contain only one known characterized isolate each.  
However, additional wild-type clinical ST68 (n=3) and ST71 (n=2) isolates were added to 
subsequent analyses to show reproducibility of mecA expression within sequence type 
background.  In total four North American ST68s, three European ST71s, and one each 
of STs 73 and 116 were fully characterized by MLST, PFGE (FIGURE 3.2b), mec and bla 














FIGURE 3.2b.  PFGE of nine MRSP isolates.  EO-50, EO-55, and EO-64 are European ST71 and closely related by the Tenover et al. criteria.  08-
1043, 08-3187, 08-494, and 06-3228 are southeastern US ST68 and closely related by the Tenover et al. criteria.  EO-69 and EO-138 are sequence 




mec Sequence Analyses 
 
Promoter sequences for ST68 and ST71 were identical.  There was a mecA promoter 
single bp polymorphism between ST73 and STs 68 and 71 at mecA -10; this was adjacent 
to a mecI/blaI TACA binding motif (solid boxes FIGURE 3.3).  Sequence type 116 differs 
from STs 68 and 71 by a single base pair difference at the mecA ribosomal binding site 
(dashed box FIGURE 3.3). 
Repressor mecI sequence was complete and presumed functional in only STs 71 and 73, 
SCCmec types II-III and VII respectively.47 In the isolates sequenced for this study, there 
was complete homology between ST71 and ST73 in the mecI open reading frame (data 
not shown). 
Sensor mecR1 sequence was similar between STs 71, 73, and 116, sharing 97% 
nucleotide homology.  The significance of the slight dissimilarity is unknown.  However, 
because only mecR1 and not blaR1 can inactivate mecI, mecR1 is presumably a non-
essential remnant in ST116.  mecR1 in ST71 differs from ST73 by a single bp deletion, 
resulting in a frame shift mutation at the C-terminal end of the peptide sequence 
(FIGURE 3.4). 
 
bla Sequence Analyses 
 
As was previously reported in “Sequence type selection for further analyses”, ST116 blaI 
genomic sequence compared with that of STs 68 and 71 had multiple nucleotide and 
translational dissimilarities (FIGURE 2).  The sensor blaR1 was 100% homologous 
between STs 68 and 71.  However, peptide composition of BlaR1 between STs 68 and 71 







FIGURE 3.3.  mecA promoter region polymorphisms of MRSP sequence types.  blaI/mecI binding motifs   











FIGURE 3.5.  blaR1 peptide dissimilarity between ST 116 and STs 71 and 73. 
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Relative Quantitation of mecA Expression –  ∆∆Ct Method 
 
Each RT-PCR value for the nine isolates below was the result of the analysis of a single 
RNA sample. However, growth experiments with RNA extraction and RT-PCR were 
performed at least twice with each isolate. 
Measurements of mecA mRNA copy number relative to that of the 16S RNA endogenous 
control allowed intra-isolate comparisons at differing time points.  This method was 
useful in illustrating the direction of mecA expression (FIGURE 3.6).   
Sequence type 73, which lacked the blaI repressor, showed a stepwise increase in mecA 
expression over four hours.  Sequence types 68 and 116, each lacking the mecI 
repressor, showed induction immediately at one hour, and then maintained elevated 
mecA expression at two and four hours.  Sequence type 71, which possessed both blaI 
and mecI repressors, did not increase mecA expression at any time point at the 0.01 





FIGURE 3.6.  Influence of repressor gene presence or absence on relative mecA expression, measured at one, two and four hours of growth following 




Quantitation of mecA Expression – Standard Curve 
 
Transcript copy number tied to absolute measurements of known mecA mRNA in a 
standard curve make possible inter-isolate comparisons at the different time points 
tested.  In addition to illustrating the direction of mecA expression, the method allows a 
copy production number to be applied to the population of cells producing mecA under 
varying oxacillin exposures (FIGURE 3.7).   
At four hours growth in 5.0 ml TSB with no oxacillin, mecA copy numbers were 5.39 
million to 1.12 million for ST 68s and 71s respectively; though a 4.81 fold difference, this 
was not statistically significant (p = 0.6475).  However, significance in mecA copy 
number disparity between ST68 (+blaI/+blaR1 -mecI/mutmecR1) and ST71 (+blaI/+blaR1 
+mecI/+mecR1) isolates were noted at all subsequent induced time points.  At one hour 
induction, mecA expression was 34.71 million to 0.97 million for ST 68s and 71s 
respectively (~35 times greater mecA expression, p = 0.0114).  At two hours induction, 
mecA expression was 23.76 million to 0.71 million for ST 68s and 71s respectively (~33 
times greater mecA expression, p = 0.0158).  At four hours induction, mecA expression 
was 38.34 million to 0.65 million for ST 68s and 71s respectively (~59 times greater 
mecA expression, p = 0.0046).   
Sequence type 116 (mutblaI/+blaR1 -mecI/+mecR1) produced mecA transcript in 
amounts equivalent to ST71 (105-106) at all time points.  Whereas ST73 (-blaI/-blaR1 
+mecI/+mecR1) while increasing mecA output in a time-dependant manner, maintained 






FIGURE 3.7. Influence of repressor gene presence or absence on absolute mecA expression, measured at one, two and four hours of growth following 




Effect of Increasing Oxacillin Concentration on mecA Expression 
 
One isolate from each sequence type was exposed to increasing amounts of oxacillin to 
determine if and at what level mecA copy number induction occurred (FIGURE 3.8). 
Absolute measurement of mecA copy number revealed a one to two log difference 
between ST68 (06 3228) and ST71 (e 64) at every oxacillin concentration at which both 
isolates grew.  No clear mecA induction level was noted for ST71; mecA copy number or 
expression did not increase with increased oxacillin concentration.  Sequence type 73 
showed no mecA induction until a two-log change in copy number at 1.0 µg/ml oxacillin.  
Sequence type 116 exhibited a dose-dependent mecA copy increase in response to 




FIGURE 3.8.  Absolute mecA transcript production over four hours at increasing concentrations of oxacillin. 
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RNAIII Expression in Conjunction with mecA Expression 
 
Measurement of RNAIII at two-hour intervals during log phase growth revealed an 
expected sequential increase in RNAIII as population density within the growth chamber 
intensified.  mecA expression for the ST68 isolate shown (FIGURE 3.9) also increased 
with increasing population density for the first five hours, and then reached a plateau 





FIGURE 3.9.  Gray columns represent RNAIII expression.  The black dashed line represents mecA 
expression over nine hours.  Error bars for columns and dashed line represent standard error of the 






The pattern of mecA expression observed in this MRSP study in part parallels previous 
reports of how mec and bla regulatory elements contribute to mecA repression in MRSA 
– BlaI is more permissive at the mecA promoter than MecI.84,85 However, because the 
acquisition of mecA by S. pseudintermedius was recent, relative to that which occurred 
in S. aureus, the identification of prevailing mec regulatory strategies in regional clones 
provides more convincing evidence as to the level of mecA regulation is required for 
successful clonal expansion.  For MRSP it appears that some level of bla regulatory 
control is needed to efficiently express methicillin resistance. 
The exclusively MecR1-controlled system (ST73) was slower than the exclusively BlaR1-
controlled systems (STs 68 and 116) to respond to oxacillin, taking hours to achieve a 
comparable response.  Sequence type 73 also had the lowest level of constitutive mecA 
expression in the absence of oxacillin exposure.   It is difficult to extrapolate these and 
other in vitro assessments (mecA expression, antimicrobial susceptibility tests, etc. 
Kirby-Bauer disc diffusion, MIC) to how infections caused by these isolates will behave in 
the patient.  However, tight control of mecA by MecI-only systems likely puts these 
MRSP and MRSA lineages at a disadvantage in the clinical setting, as induction may not 
be rapid enough to prevent cell death when faced with therapeutic levels of beta-lactam 
antibiotics.81,95 The paucity of successful mec-only controlled methicillin-resistant 
lineages for both S. aureus and S. pseudintermedius suggests that some level of bla 
control in mecA expression is necessary for geographic clonal expansion.   
Despite having similar bla and mec regulatory apparatuses (blaI repression without 
mecI), sequence types 68 and 116 are genetically dissimilar when analyzed by MLST and 
PFGE, and contain the distinct SCCmec types V and VI respectively.  BLAST analysis of 
blaI and blaR1 sequence reveals differing origins for beta-lactamase.  Sequence type 116 
bla sequence is identical to S. aureus plasmid pWBG748 (GenBank accession no. 
GQ915265); whereas ST68 bla sequence matches most closely with beta-lactamase-
containing S. aureus plasmid pWBG756 (GenBank accession no. GQ900472).  Both 
sequence types respond to oxacillin induction at one-hour post induction and maintain 
increased mecA expression at two and four hours.  However, mecA transcript copy 
number differs between the two sequence types by one to two logs at all time points 
and  at all oxacillin concentrations measured, suggesting that either the blaI/blaR1 of 
ST68 is more permissive than the blaI/blaR1 of ST116, or that additional factors are 
affecting mecA expression.   
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With the singleton comparator strains (STs 73 and 116) removed from the analysis, the 
one to two log difference in mecA expression between the North American MRSP ST68s 
and European ST71s at all induced time points and at all levels of antibiotic exposure 
suggests there exists at least two divergent pathways to geographic clonal success with 
regard to control of PBP2a metabolism.   Sequence types 68 and 71 are not genetically 
similar when analyzed with MLST and PFGE.77 However, sequence analysis revealed 
complete homology in all shared mec and bla regulatory elements – mec promoter, blaI 
and blaR1.  Sequence type 68 induces at one hour and maintains induction throughout 
the assay. Whereas ST71 does not induce in the presence of 0.01 µg/ml oxacillin and 
maintains essentially the same level of constitutive mecA expression at all time points 
measured.  Presumably BlaI and MecI compete for access to the mec operator in ST 71.   
This competition could account for the variability observed in the direction of mecA 
expression.  With increasing oxacillin concentrations ST 71 appears to have a biphasic 
response with increased mecA copy number at 0.08 µg/ml and then again at 1.0 µg/ml.  
This pattern should be further explored to determine whether BlaR1 and MecR1 differ 
in response to oxacillin concentration as well as time. 
As of yet there is no known overlap in the geographic areas affected by STs 68 and 71.  
These predominant sequence types emerging in North America and Europe with their 
distinct mec regulatory strategies are either the product of chance, or are a reflection of 
unique environmental pressures.  Sequence type 68 has only BlaI/BlaR1 regulation of 
mecA, has high constitutive mecA expression, and responds rapidly to small 
concentrations of oxacillin.  Sequence type 71 has both BlaI/BlaR1 and MecI/MecR1 
regulation of mecA, and has less constitutive and induced expression of mecA than 
ST68.  Because uncontrolled PBP2a production is deleterious86, it has been suggested 
that MRSA lineages require some level of bla regulatory control to stabilize the mecA 
gene in the absence of beta-lactam antibiotic exposure.85, 91 MecI/MecR1 alone is likely 
too restrictive of mecA expression to adequately respond to beta-lactam treatment.  
MecI/MecR1 coupled with BlaI/BlaR1 represents a middle ground with ST71 where a 
lineage could call on mecA expression if needed; this conformation may indicate that 
these isolates evolved in an environment in which antibiotic perturbations were less 
frequent.  The BlaI/BlaR1 of ST 68 represents the least stringent mecA control, and the 
apparent success of this lineage in the United States may indicate a constant need for 
some level of PBP2a, possibly due to presence of low-level beta-lactam in the 




Chapter 4: Conclusions and Application of Findings 
 
The molecular characterization study is now part of a collection of similar 
investigations33,45,46,77 that have firmly established ST71 and ST68 MRSP clonal 
expansion in Europe and US respectively. The follow-up study is the first to utilize 
comparative regulatory gene sequencing and gene expression in MRSP to compare the 
two regional clones with regard to differences in gene expression.  The approach used in 
measuring mecA copy number gave unique insight into not only fold change over 
baseline expression, but absolute copy number of mecA mRNA produced in MRSP.   
Sequence type 68 exhibited a significantly different mecA response relative to ST71 in 
quickness, duration, and number of transcripts when exposed to very small amounts of 
oxacillin.  This presumably translates to greater PBP2a in ST68 relative to ST71 within 
the first few hours of oxacillin exposure.  Earlier MRSA studies have not been able to 
detect a correlation between beta-lactam mean inhibitory concentration (phenotype) 
and cellular concentrations of PBP2a.96,97 We too observed that high and low mecA 
production response did not correspond to phenotype.  Isolates of ST68 and ST71 
exhibited a full range of phenotypic oxacillin resistance, from low-level measurements 
near 17 mm by Kirby-Bauer disc diffusion and 0.5 µg/ml by broth microdilution to high-
level resistance ≤ 10 mm and ≥ 4.0 µg/ml respecitively.77,98 This discrepancy between 
reproducible amounts of mecA transcript production (measured at one, two and four 
hours of oxacillin exposure) and variable disc diffusion phenotype (typically measured at 
24 hours of bacterial growth) suggests that expression analysis may be more indicative 
of in vivo MRSP response to antibiotic therapy than more traditional measurements.  
Clinicians select antibiotics and dosage based upon phenotypic measurements.  But 
these finding perhaps indicate more aggressive empirical beta-lactam protocols could be 
beneficial against clonal lineages like ST71 in Europe that demonstrate more stringent 
mecA regulatory control.  Further research would be required to bear this out. 
In 2003 Rosato et al performed a similar analysis of clinical MRSA isolates, sequencing 
regulatory genes and the mecA promoter, and performing mecA expression analysis.  
They reported a synergism in isolates with both MecI and BlaI, with lower mecA 
transcription than isolates containing either one alone.84 Our observations of MRSP in 
Chapter 3 conflict with the Rosato assessment – ST71 with both BlaI and MecI was 
intermediate to the high mecA production of ST68 and the low mecA production of 
MecI-only ST73.  The less-diversified MRSP genetic evolutionary picture may explain this 
difference.  Heterogeneous resistance is a strategy in many successful MRSA lineages, 
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whereby a small subset of bacterial cells in pure culture express high-level methicillin 
resistance in response to selection.  Multiple genetic factors (in addition to those 
examined in these studies) have been shown to affect mecA production in MRSA.  We 
have been unable to demonstrate heterogeneous methicillin resistance thus far in 
MRSP.  Perhaps this early less complicated stage of mecA regulatory evolution in MRSP 
can be exploited.  We’ve demonstrated that some level of beta-lactamase control likely 
contributes to the success of STs 68 and 71.  Our findings suggest that the membrane-
bound receptor BlaR1 as a prime target for therapeutic control of methicillin-resistant 
isolates.   
The most lasting aspect of this work will likely be the development of a highly 
reproducible MRSP mecA expression assay as an in vitro model to analyze novel 
antibiotic approaches.  New antibiotics from the traditional development pipelines are 
slow in coming and quick to select for resistance.  Our model can be used in conjunction 
with any approach that could hinder the production of mecA and reinstate the 
effectiveness of synthetic beta-lactam antibiotics.  The development of a BlaR1- and/or 
PBP2a-specific vaccine, the effect of non-cognate auto-inducing peptides, and the 
activity of synthetic antisense oligonucleotides on mecA regulatory genes could all 
readily be assessed using the mecA expression assay.   
MRSP was first identified in 1999.5 UTCVM has been at the forefront of research 
institutions in tracking the proliferation of this emerging pathogen from phenotypic, 
molecular, and clinical perspectives.  At the beginning of this project in 2007 the first 
publication hinting at regional clonality had just been published.33 In the time since, this 
dissertation project has contributed to the MRSP knowledge-base with the identification 
of ST68 as the regional clone associated with our collection and the United States, and 
has brought to light the significant differences in mecA expression strategies between 
the European and American regional clones.  
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